Pfizer launches mRNA flu vaccine trial
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
More and more countries around the world are struggling with a new wave of infections, with an alarming increase in COVID-19 cases. Mostly these new surges are attributed to variants of SARS-CoV-2.
Apr 16, 2021
0
5
Twenty years ago this month, the first draft of the human genome was publicly released. One of the major surprises that came from that project was the revelation that only 1.5 percent of the human genome consists of protein-coding ...
Feb 3, 2021
0
98
While our circadian body clock dictates our preferred rhythm of sleep or wakefulness, a relatively new concept—the epigenetic clock—could inform us about how swiftly we age, and how prone we are to diseases of old age.
Oct 29, 2020
0
263
Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and ...
Aug 5, 2020
0
120
While the exact origin of the coronavirus remains murky, scientists have been racing to determine how it jumped from animals to humans so they can prevent another pandemic.
Aug 4, 2020
1
3
What is this enemy?
Jul 15, 2020
0
3
Researchers from CSIRO, Australia's national science agency, have unveiled a new approach to analysing the genetic codes—or the blueprint—of the SARS-CoV-2 virus that causes COVID-19.
Apr 19, 2020
0
320
Humans have long been thwarted by 'the fever'. References to malaria's infamous febricity are found across antiquity, from writings by the four thousand-year-old Vedic sages of ancient India to the Greek physician Hippocrates. ...
Dec 19, 2019
0
15
French pharmaceutical giant Sanofi said on Monday it had agreed to buy US biotech firm Synthorx to boost its immuno-oncology portfolio.
Dec 9, 2019
0
3